| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,130 |
7,711 |
$566K |
| S9083 |
Global fee urgent care centers |
3,083 |
2,717 |
$348K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
4,304 |
3,714 |
$326K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,332 |
2,848 |
$180K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,665 |
2,255 |
$175K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
5,733 |
4,403 |
$79K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,194 |
2,181 |
$63K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,326 |
1,085 |
$28K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
457 |
265 |
$23K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
7,398 |
2,818 |
$21K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,597 |
1,883 |
$7K |
| 0012A |
|
42 |
39 |
$2K |
| 99215 |
Prolong outpt/office vis |
21 |
19 |
$2K |
| 0011A |
|
49 |
45 |
$1K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
16 |
15 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
516 |
357 |
$964.75 |
| 99051 |
|
16 |
16 |
$171.20 |
| 87807 |
|
117 |
59 |
$157.20 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
168 |
120 |
$51.40 |
| 81025 |
|
18 |
12 |
$50.50 |
| 81003 |
|
95 |
39 |
$38.50 |
| 91301 |
|
90 |
84 |
$37.08 |
| S9088 |
Services provided in an urgent care center (list in addition to code for service) |
301 |
281 |
$0.00 |